Literature DB >> 26461941

Compassionate and optimum use of new tuberculosis drugs.

Alberto Matteelli1, Lia D'Ambrosio2, Rosella Centis3, Marina Tadolini4, Giovanni Battista Migliori5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26461941     DOI： 10.1016/S1473-3099(15)00296-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

Review 1.  Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

Authors:  Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Marina Tadolini; Margareth Dalcolmo; Adrian Rendon; Susanna Esposito; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.

Authors:  L Guglielmetti; C Hewison; Z Avaliani; J Hughes; N Kiria; N Lomtadze; N Ndjeka; S Setkina; A Shabangu; W Sikhondze; A Skrahina; N Veziris; J Furin
Journal:  Int J Tuberc Lung Dis       Date:  2017-02-01       Impact factor: 2.373

Review 3.  Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Susanna Esposito; Simone Dore; Antonio Spanevello; Giovanni Battista Migliori
Journal:  Int J Mol Sci       Date:  2016-03-12       Impact factor: 5.923

Review 4.  New Antituberculosis Drugs: From Clinical Trial to Programmatic Use.

Authors:  Gina Gualano; Susanna Capone; Alberto Matteelli; Fabrizio Palmieri
Journal:  Infect Dis Rep       Date:  2016-06-24

Review 5.  Recent developments in the diagnosis and management of tuberculosis.

Authors:  Giorgia Sulis; Rosella Centis; Giovanni Sotgiu; Lia D'Ambrosio; Emanuele Pontali; Antonio Spanevello; Alberto Matteelli; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-03       Impact factor: 2.871

Review 6.  Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Battista Migliori; Emanuele Pontali; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Marina Tadolini; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

7.  First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.

Authors:  Marina Tadolini; Rangjung Dolma Lingtsang; Simon Tiberi; Martin Enwerem; Lia D'Ambrosio; Tsetan Dorji Sadutshang; Rosella Centis; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2016-06-10       Impact factor: 16.671

8.  Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.

Authors:  Marina Tadolini; Anthony J Garcia-Prats; Lia D'Ambrosio; Catherine Hewison; Rosella Centis; H Simon Schaaf; Ben J Marais; Hannetjie Ferreira; Jose A Caminero; Sylvie Jonckheere; Animesh Sinha; Krzysztof Herboczek; Zarema Khaidarkhanova; Armen Hayrapetyan; Naira Khachatryan; Ia Urtkmelidze; Carolina Loreti; Susanna Esposito; Alberto Matteelli; Jennifer Furin; Francis Varaine; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2016-06-23       Impact factor: 16.671
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.